Cancer Research Legislation
This page provides summaries of legislation proposed in the 116th Congress specific to particular diseases, as well as other topics such as childhood cancer and cancer survivorship. This page will be updated as relevant legislation is introduced.
Henrietta Lacks Enhancing Cancer Research Act of 2019 (H.R. 1966, S. 946)
- The legislation was introduced on 3/28/19 by Rep. Elijah Cummings (D-MD) in the House and Sen. Chris Van Hollen (D-MD) in the Senate. The House bill was referred to the Committee on Energy & Commerce the Senate bill was referred to the Committee on Health, Education, Labor, and Pensions.
- The bill calls for the Government Accountability Office (GAO) to complete a study that reviews actions taken by federal agencies to help to address barriers to participation in federally funded cancer clinical trials by populations that have been traditionally underrepresented in such trials. The legislation also instructs the GAO to identify additional actions that can be taken by federal agencies to address these barriers and to submit a report to Congress on the results of the study, including the GAO recommendations.
- The legislation notes that the study should include review of cancer clinical trials that are largely funded by Federal agencies, including the NIH.
Women and Lung Cancer Research and Preventive Services Act of 2019 (H.R. 2222, S. 1107)
- The legislation was introduced on 4/10/19 by Rep. Brendan Boyle (D-PA) in the House and Sen. Marco Rubio (R-FL) in the Senate. The House bill was referred to the Committee on Energy & Commerce and the Senate bill was referred to the Committee on Health, Education, Labor, and Pensions.
- The bills would encourage more research into the prevention and treatment of lung cancer in women, particularly for those who have never smoked, and would require federal agencies to evaluate and report their findings to Congress.
Breast Cancer Research Stamp Reauthorization Act of 2019 (H.R. 2689, S. 1438)
- The legislation was introduced on 5/14/19 by Rep. Jackie Speier (D-CA) in the House and Sen. Dianne Feinstein (D-CA) in the Senate.
- The legislation would extend the authority of the United States Postal Service to issue a semi postal to raise funds for breast cancer research from 2019 to 2027. Currently, seventy percent of the net proceeds from the Breast Cancer Research Stamp surcharge go to the NIH for breast cancer research and 30 percent to the Department of Defense for the same purpose.
- The House passed an amendment to the National Defense Authorization Act (NDAA) on 6/19/19 that would reauthorize the Breast Cancer Research Stamp through 2027. The full NDAA has yet to receive a vote in the House or Senate.